Diagnosis of acquired bone marrow failure syndrome during childhood using the 2008 World Health Organization classification system

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International journal of hematology

• Publication date

  2012-05-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12185-012-1092-zPMID 22562435
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach

  2009cited by this paper
• Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.

  2007cited by this paper
• Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS)

  2005cited by this paper
• Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival.

  2005cited by this paper
• The impact of Asian descent on the incidence of acquired severe aplastic anaemia in children

  2003influential reference
• Relative erythroid hyperplasia in the bone marrow at diagnosis of aplastic anaemia: a predictive marker for a favourable response to cyclosporine therapy

  1996cited by this paper
• Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study.

  1987cited by this paper
• Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

  1976cited by this paper

• Differentiating primary bone marrow failure syndromes in children: a retrospective analysis of early clinical and laboratory features

  2025cites this paper
• Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia

  2023cites this paper
• Prospective validation of the provisional entity of refractory cytopenia of childhood, proposed by the World Health Organization

  2021cites this paper
• The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.

  2021cites this paper
• Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamide

  2020cites this paper
• Updated Guidelines for the Treatment of Acquired Aplastic Anemia in Children

  2018cites this paper
• Differences in the bone marrow histology between childhood myelodysplastic syndrome with multilineage dysplasia and refractory cytopenia of childhood without multilineage dysplasia

  2018cites this paper
• Bone Marrow Failure Syndromes in Children

  2017cites this paper
• Why is the incidence of aplastic anemia higher in Asia?

  2017cites this paper
• Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine

  2015cites this paper
• Pediatric myelodysplastic syndromes

  2015cites this paper
• Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors

  2015cites this paper